Natera Inc Director Herm Rosenman Sells 93,901 Shares
Herm Rosenman, a director at Natera Inc (NASDAQ:NTRA), sold 93,901 shares of the company on February 16, 2024, according to a recent SEC Filing.
Stay updated with breaking news from Prenatal Tests. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Herm Rosenman, a director at Natera Inc (NASDAQ:NTRA), sold 93,901 shares of the company on February 16, 2024, according to a recent SEC Filing.
Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), executed a sale of 2,973 shares in the company on January 23, 2024, according to a recent SEC Filing.
Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), executed a sale of 2,292 shares in the company on December 29, 2023, according to a recent SEC Filing.
NEW DELHI, Mar 6: In order to commemorate World Rare Disease Day, the Organization for Rare Diseases India (ORDI) would organise the 8th edition of Racefor7 on March 12 in New Delhi. The annual event by ORDI would raise awareness about the rare disease community and advocate better policies and access to treatment for rare disease patients. Speaking at the event, Dr Neerja Gupta, Additional Professor, Division of Genetics, Department of Pediatrics, AIIMS, New Delhi said “Rare diseases now have […]
Molecular Diagnostics Market study by "Data Bridge Market Research" provides details about the market dynamics affecting this market, Market scope, Market